NASDAQ:ETON • US29772L1089
Past quarterly earnings results for ETON PHARMACEUTICALS INC (ETON), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.07 | 0.09 | -176.25% | -333.33% | 22.459M | 20.883M | 7.55% | 117.54% |
| Q2 2025 | -0.10 | -0.04 | -167.36% | 16.67% | 18.928M | 17.046M | 11.04% | 108.60% |
| Q1 2025 | 0.07 | 0.05 | 28.68% | 333.33% | 17.282M | 15.434M | 11.97% | 116.95% |
| Q4 2024 | -0.02 | 0.00 | -488.82% | 77.78% | 11.647M | 10.741M | 8.43% | 59.26% |
| Q3 2024 | 0.03 | -0.01 | 394.12% | 250.00% | 10.324M | 9.889M | 4.40% | 46.90% |
| Q2 2024 | -0.12 | -0.07 | -68.07% | -180.00% | 9.074M | 8.976M | 1.09% | -24.36% |
| Q1 2024 | -0.03 | -0.05 | 34.64% | 70.00% | 7.966M | 8.16M | -2.38% | 50.19% |
| Q4 2023 | -0.09 | -0.04 | -120.59% | -325.00% | 7.313M | 7.854M | -6.89% | -13.96% |
| Q3 2023 | -0.02 | -0.10 | 80.39% | 83.33% | 7.028M | 6.384M | 10.09% | 118.26% |
| Q2 2023 | 0.15 | -0.09 | 263.40% | 350.00% | 11.997M | 6.639M | 80.70% | 63.00% |
| Q1 2023 | -0.10 | -0.14 | 29.97% | 52.38% | 5.304M | 4.647M | 14.14% | 143.30% |
| Q4 2022 | 0.04 | 0.01 | 292.16% | - | 8.5M | 9.301M | -8.61% | 39.57% |
| Q3 2022 | -0.12 | -0.15 | 21.57% | 50.00% | 3.22M | 3.11M | 3.54% | 312.82% |
| Q2 2022 | -0.06 | 0.03 | -296.08% | 40.00% | 7.36M | 7.92M | -7.07% | 139.74% |
| Q1 2022 | -0.21 | -0.08 | -157.35% | -210.53% | 2.18M | 7.242M | -69.90% | -81.68% |
| Q4 2021 | 0.04 | 0.19 | -79.36% | 112.50% | 6.09M | 12.768M | -52.30% | 7,512.50% |
| Q3 2021 | -0.24 | -0.14 | -74.29% | 22.58% | 780K | 3.102M | -74.85% | 587.50% |
| Q2 2021 | -0.10 | -0.14 | 29.97% | 56.52% | 3.07M | 3.887M | -21.02% | 15,250.00% |
| Q1 2021 | 0.19 | 0.19 | -1.96% | 138.00% | 11.9M | 12.295M | -3.21% | 11,800.00% |
| Q4 2020 | -0.32 | -0.27 | -20.66% | - | 80K | 1.361M | -94.12% | - |
| Q3 2020 | -0.31 | -0.26 | -19.97% | - | -160K | 1.519M | -110.53% | - |
| Q2 2020 | -0.23 | -0.27 | 13.27% | - | 20K | 300.217K | -93.34% | - |
| Q1 2020 | -0.50 | -0.23 | -119.49% | - | 100K | 1.545M | -93.53% | - |
Notes
ETON PHARMACEUTICALS INC (ETON) last reported earnings on 11/6/2025.
ETON PHARMACEUTICALS INC (ETON) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, ETON PHARMACEUTICALS INC (ETON) has beaten EPS estimates in 1 out of 4 releases.